Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 7 | 2022 | 3521 | 0.990 |
Why?
|
Platinum | 1 | 2020 | 233 | 0.660 |
Why?
|
Platinum Compounds | 1 | 2016 | 96 | 0.540 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 306 | 0.530 |
Why?
|
Data Mining | 2 | 2018 | 537 | 0.520 |
Why?
|
Artificial Intelligence | 2 | 2018 | 2214 | 0.520 |
Why?
|
Lung Neoplasms | 5 | 2020 | 13102 | 0.510 |
Why?
|
Rare Diseases | 1 | 2019 | 553 | 0.480 |
Why?
|
Tuberous Sclerosis | 2 | 2020 | 1029 | 0.470 |
Why?
|
Proteomics | 5 | 2018 | 3638 | 0.460 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 4838 | 0.440 |
Why?
|
Proteome | 3 | 2018 | 1799 | 0.440 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2924 | 0.430 |
Why?
|
Metabolomics | 2 | 2018 | 1484 | 0.430 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4034 | 0.430 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1584 | 0.400 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6364 | 0.370 |
Why?
|
Decision Support Techniques | 1 | 2020 | 1956 | 0.370 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5319 | 0.370 |
Why?
|
Lung | 3 | 2017 | 9856 | 0.360 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.340 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3703 | 0.340 |
Why?
|
Lymph Nodes | 1 | 2020 | 3474 | 0.330 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11031 | 0.330 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.300 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 7913 | 0.290 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3046 | 0.290 |
Why?
|
Search Engine | 2 | 2018 | 144 | 0.290 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3143 | 0.270 |
Why?
|
Twins, Dizygotic | 2 | 2016 | 236 | 0.260 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4262 | 0.240 |
Why?
|
Twins, Monozygotic | 2 | 2016 | 458 | 0.240 |
Why?
|
ROC Curve | 3 | 2021 | 3527 | 0.230 |
Why?
|
Schizophrenia | 1 | 2022 | 6882 | 0.220 |
Why?
|
Neoplasms | 4 | 2021 | 21683 | 0.220 |
Why?
|
Prognosis | 8 | 2022 | 29063 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5221 | 0.200 |
Why?
|
Models, Biological | 1 | 2017 | 9583 | 0.190 |
Why?
|
Labor, Induced | 1 | 2021 | 146 | 0.180 |
Why?
|
Humans | 40 | 2022 | 744343 | 0.180 |
Why?
|
Area Under Curve | 2 | 2022 | 1654 | 0.180 |
Why?
|
Professional Competence | 2 | 2014 | 447 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11725 | 0.160 |
Why?
|
Drug Eruptions | 1 | 2021 | 297 | 0.160 |
Why?
|
Thyrotropin | 1 | 2021 | 849 | 0.160 |
Why?
|
Human Genome Project | 1 | 2018 | 193 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2021 | 8949 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20129 | 0.150 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2017 | 150 | 0.150 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1038 | 0.140 |
Why?
|
Cell Dedifferentiation | 1 | 2017 | 135 | 0.140 |
Why?
|
Exanthema | 1 | 2021 | 501 | 0.140 |
Why?
|
Twin Studies as Topic | 1 | 2016 | 105 | 0.140 |
Why?
|
Comorbidity | 2 | 2022 | 10388 | 0.130 |
Why?
|
Mutation | 2 | 2021 | 29786 | 0.130 |
Why?
|
Quality Control | 1 | 2018 | 841 | 0.130 |
Why?
|
Cultural Characteristics | 2 | 2014 | 262 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17446 | 0.130 |
Why?
|
Students, Nursing | 1 | 2014 | 45 | 0.120 |
Why?
|
Algorithms | 3 | 2020 | 13881 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 198 | 0.120 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2016 | 406 | 0.110 |
Why?
|
Birth Weight | 1 | 2021 | 2069 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1380 | 0.110 |
Why?
|
Social Values | 1 | 2014 | 224 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 476 | 0.110 |
Why?
|
Female | 18 | 2022 | 380194 | 0.110 |
Why?
|
Tacrolimus | 1 | 2016 | 743 | 0.110 |
Why?
|
Pathology, Clinical | 1 | 2016 | 368 | 0.110 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 450 | 0.110 |
Why?
|
Lymphoma | 1 | 2021 | 1877 | 0.100 |
Why?
|
Morphogenesis | 1 | 2015 | 752 | 0.100 |
Why?
|
Databases, Protein | 1 | 2013 | 383 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2020 | 1185 | 0.100 |
Why?
|
Middle Aged | 10 | 2021 | 213383 | 0.100 |
Why?
|
Infant, Newborn | 4 | 2020 | 25625 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8863 | 0.090 |
Why?
|
Cisplatin | 1 | 2016 | 1662 | 0.090 |
Why?
|
Medical Informatics | 1 | 2017 | 745 | 0.090 |
Why?
|
Infant, Premature | 2 | 2016 | 2044 | 0.090 |
Why?
|
Aged | 9 | 2021 | 163280 | 0.090 |
Why?
|
Premature Birth | 1 | 2021 | 1721 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2019 | 952 | 0.090 |
Why?
|
Research | 1 | 2018 | 1999 | 0.090 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11366 | 0.080 |
Why?
|
Cell Cycle | 1 | 2017 | 2967 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4215 | 0.080 |
Why?
|
Suicide | 1 | 2019 | 1477 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1099 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6773 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6538 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.080 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1637 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2133 | 0.080 |
Why?
|
Male | 13 | 2021 | 350118 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3507 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2716 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3481 | 0.070 |
Why?
|
Decision Making | 1 | 2019 | 3887 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.070 |
Why?
|
Adolescent | 4 | 2022 | 85781 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 2872 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1736 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 5987 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2461 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35421 | 0.060 |
Why?
|
Melanoma | 1 | 2021 | 5510 | 0.050 |
Why?
|
China | 2 | 2021 | 2248 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 23338 | 0.050 |
Why?
|
Taiwan | 2 | 2014 | 496 | 0.050 |
Why?
|
Apgar Score | 1 | 2021 | 123 | 0.050 |
Why?
|
United States | 5 | 2021 | 69872 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1862 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15076 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9438 | 0.050 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12261 | 0.050 |
Why?
|
Genomics | 1 | 2016 | 5720 | 0.040 |
Why?
|
Child | 4 | 2022 | 77709 | 0.040 |
Why?
|
Depression | 1 | 2019 | 7766 | 0.040 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 250 | 0.040 |
Why?
|
Infant | 2 | 2018 | 35136 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 56430 | 0.040 |
Why?
|
Adult | 7 | 2021 | 214055 | 0.040 |
Why?
|
Hearing | 1 | 2020 | 482 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15295 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15519 | 0.040 |
Why?
|
Inverted Repeat Sequences | 1 | 2016 | 61 | 0.040 |
Why?
|
Public Health Informatics | 1 | 2017 | 110 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 41006 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4567 | 0.030 |
Why?
|
Prospective Studies | 2 | 2019 | 53288 | 0.030 |
Why?
|
Chromosomal Instability | 1 | 2016 | 184 | 0.030 |
Why?
|
Ethics, Nursing | 1 | 2014 | 25 | 0.030 |
Why?
|
Blood Specimen Collection | 1 | 2015 | 246 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2011 | 7880 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2015 | 328 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26385 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13695 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2016 | 63114 | 0.030 |
Why?
|
Altruism | 1 | 2014 | 204 | 0.030 |
Why?
|
Cities | 1 | 2014 | 513 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 20947 | 0.030 |
Why?
|
Forecasting | 1 | 2021 | 2951 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1252 | 0.030 |
Why?
|
Annexin A4 | 1 | 2011 | 9 | 0.020 |
Why?
|
Social Responsibility | 1 | 2014 | 389 | 0.020 |
Why?
|
alpha-Defensins | 1 | 2011 | 28 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2015 | 591 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1758 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1706 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 651 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 21746 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 349 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2203 | 0.020 |
Why?
|
Models, Educational | 1 | 2011 | 377 | 0.020 |
Why?
|
Ethics, Medical | 1 | 2014 | 792 | 0.020 |
Why?
|
Developed Countries | 1 | 2011 | 437 | 0.020 |
Why?
|
Professional Role | 1 | 2011 | 306 | 0.020 |
Why?
|
Animals | 2 | 2018 | 168757 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2022 | 7785 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1990 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4149 | 0.020 |
Why?
|
Patient Participation | 1 | 2017 | 1457 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13408 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2046 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2715 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12959 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 602 | 0.020 |
Why?
|
Blood Proteins | 1 | 2011 | 1124 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3743 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1157 | 0.020 |
Why?
|
Diet | 1 | 2022 | 7939 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4803 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2016 | 3821 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 72290 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10252 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4420 | 0.010 |
Why?
|
Consensus | 1 | 2011 | 2959 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8388 | 0.010 |
Why?
|
Health Promotion | 1 | 2014 | 2205 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57776 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39050 | 0.010 |
Why?
|
Communication | 1 | 2014 | 3749 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29144 | 0.010 |
Why?
|
Education, Medical | 1 | 2011 | 1721 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
Developing Countries | 1 | 2011 | 2815 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13815 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4409 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12245 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12354 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8428 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81183 | 0.000 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_